Amgen Returns Eczema Drug To Kyowa Kirin On Marketability Doubts

 
• By Joseph Haas
  
Broken
Amgen is terminating its deal with Kyowa Kirin around atopic dermatitis drug rocatinlimab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business